Henry Schein price target raised to $75 from $69 at Leerink

Leerink analyst Michael Cherny raised the firm’s price target on Henry Schein (HSIC) to $75 from $69 and keeps a Market Perform rating on the shares. Heading into Q2 earnings, the firm is updating dental company estimates and publishing the results of its fourth semi-annual dental survey of 63 dental practitioners in the United States. There is clearly a budding interest in identifying incremental improvements across the dental space, even if each opportunity seems to be company-specific in what remains a still-challenged total dental end-market, Leerink says. The firm sees reasons to be positive on each stock in its coverage but also has some offsetting questions that limit too much constructiveness.